HC Wainwright Reaffirms “Neutral” Rating for Lyell Immunopharma (NASDAQ:LYEL)
Lyell Immunopharma (NASDAQ:LYEL – Get Free Report)‘s stock had its “neutral” rating reissued by stock analysts at HC Wainwright in a research note issued to investors on Thursday,Benzinga reports. They presently have a $1.00 target price on the stock. HC Wainwright’s target price points to a potential upside of 70.82% from the company’s previous close. […]
Lyell Immunopharma (NASDAQ:LYEL – Get Free Report)‘s stock had its “neutral” rating reissued by stock analysts at HC Wainwright in a research note issued to investors on Thursday,Benzinga reports. They presently have a $1.00 target price on the stock. HC Wainwright’s target price points to a potential upside of 70.82% from the company’s previous close. […]
